NO20080800L - Kimaere antistoffer med New World primat regioner - Google Patents

Kimaere antistoffer med New World primat regioner

Info

Publication number
NO20080800L
NO20080800L NO20080800A NO20080800A NO20080800L NO 20080800 L NO20080800 L NO 20080800L NO 20080800 A NO20080800 A NO 20080800A NO 20080800 A NO20080800 A NO 20080800A NO 20080800 L NO20080800 L NO 20080800L
Authority
NO
Norway
Prior art keywords
regions
new world
chimeric antibodies
world primate
cdr
Prior art date
Application number
NO20080800A
Other languages
English (en)
Norwegian (no)
Inventor
Philip Anthony Jennings
Anthony Gerard Doyle
Adam William Clarke
Original Assignee
Arana Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005904406A external-priority patent/AU2005904406A0/en
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of NO20080800L publication Critical patent/NO20080800L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20080800A 2005-08-15 2008-02-14 Kimaere antistoffer med New World primat regioner NO20080800L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies
PCT/AU2006/001166 WO2007019621A1 (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Publications (1)

Publication Number Publication Date
NO20080800L true NO20080800L (no) 2008-05-09

Family

ID=37757238

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080800A NO20080800L (no) 2005-08-15 2008-02-14 Kimaere antistoffer med New World primat regioner

Country Status (13)

Country Link
EP (1) EP1945669A4 (de)
JP (1) JP2009504686A (de)
KR (1) KR20080068005A (de)
CN (2) CN101287763A (de)
AU (1) AU2006281981A1 (de)
BR (2) BRPI0614867A2 (de)
CA (1) CA2619245A1 (de)
MX (1) MX2008002161A (de)
NO (1) NO20080800L (de)
NZ (1) NZ565904A (de)
RU (1) RU2008110058A (de)
WO (1) WO2007019621A1 (de)
ZA (2) ZA200802247B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647625B2 (en) 2004-07-26 2014-02-11 Biogen Idec Ma Inc. Anti-CD154 antibodies
AU2007211829C9 (en) 2006-02-01 2013-07-11 Cephalon Australia Pty Ltd Domain antibody construct
PL2125894T3 (pl) * 2007-03-22 2019-08-30 Biogen Ma Inc. Białka wiążące, w tym przeciwciała, pochodne przeciwciał i fragmenty przeciwciał, które swoiście wiążą się z CD154 i ich zastosowania
CA2733742A1 (en) * 2008-08-14 2010-02-18 Cephalon Australia Pty Ltd Variant domain antibodies
RU2535034C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2517085C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2516931C2 (ru) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2521392C2 (ru) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний
RU2577299C2 (ru) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
RU2519862C2 (ru) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2579262C1 (ru) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения инфекционных заболеваний
CL2015002152A1 (es) * 2015-07-31 2016-06-03 Pontificia Universidad Católica De Chile Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1266965B1 (de) * 1991-07-25 2006-05-24 Biogen Idec Inc. Rekombinante Antikörper zur humanen Therapie
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
ATE328906T1 (de) * 2002-06-28 2006-06-15 Domantis Ltd Dual-specifische liganden mit erhöhter halbwertszeit
JP2007534305A (ja) * 2003-11-07 2007-11-29 アムジェン インコーポレイテッド サル免疫グロブリン配列

Also Published As

Publication number Publication date
JP2009504686A (ja) 2009-02-05
EP1945669A1 (de) 2008-07-23
AU2006281981A1 (en) 2007-02-22
CN101287763A (zh) 2008-10-15
WO2007019621A1 (en) 2007-02-22
EP1945669A4 (de) 2009-07-22
KR20080068005A (ko) 2008-07-22
NZ565904A (en) 2012-02-24
CN101287762A (zh) 2008-10-15
ZA200802247B (en) 2009-08-26
ZA200802246B (en) 2009-09-30
BRPI0614430A2 (pt) 2011-03-29
BRPI0614867A2 (pt) 2012-01-31
CA2619245A1 (en) 2007-02-22
RU2008110058A (ru) 2009-09-27
MX2008002161A (es) 2008-04-22

Similar Documents

Publication Publication Date Title
NO20080800L (no) Kimaere antistoffer med New World primat regioner
NO20080799L (no) Omkonstruerte antistoffer med New World primate rammeverksregioner
CR20110577A (es) Proteínas de unión a il-1
NI201400019A (es) Anticuerpo anti-alfabetatcr
DK1716181T3 (da) CDR-reparerede antistoffer
ATE520716T1 (de) Humanisierter anti-cd4-antikörper mit immunsuppressiven eigenschaften
CR8958A (es) Anticuerpos Anti-5T4 humanizados y conjugados de anticuerpos anti-5T4/caliqueamicina
NO20074867L (no) Antistoffer mot CCR5 og anvendelser derav
WO2008006235A3 (en) Scfv antibodies which pass epithelial and/or endothelial layers
RS52176B (en) HIGH AFINITY ANTIBODIES TO THE HUMAN IL-6 RECEPTOR
EA201590208A1 (ru) Усиление активности т-клеток car путем совместного введения биспецифического антитела
CO6781489A2 (es) Proteínas de unión al tnf-α
RS53760B1 (en) HUMAN ANTIBODIES RELATING TO MESOTELINE AND THEIR USES
NZ718973A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PE20141398A1 (es) Anticuerpos neutralizantes de citomegalovirus humano
WO2013054331A8 (en) Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
MY188368A (en) Interleukin-13 binding proteins
RS52332B (en) HUMAN ANTI-NGF NEUTRAL ANTIBODIES AS SELECTIVE NGF SIGNAL ROUTE INHIBITORS
NO20066052L (no) Anti-CD3 antistoffer og fremgangsmater for anvendelse derav
RU2531523C3 (ru) Стабильные и растворимые антитела, ингибирующие vegf
NZ611269A (en) Neutralizing anti-ccl20 antibodies
RS53120B (en) ANTAGONISTIC HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO THE HUMAN LIGHT
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
NZ602676A (en) Anti-vla-4 antibodies
NZ600915A (en) Humanised antibodies with anti-tumour activity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application